|
Pfizer admits heart attack risk for Bextra.
->Read More...
On October 16, 2004, The New York times reported that Pfizer warned doctors about Bextra posing an increased risk of heart attack or stroke in coronary artery bypass surgery patients...
Bextra Heart Attacks.
->Read More...
Pfizer admits that the Cox-2 drug Bextra is linked to heart problems. Clinical trials showed heart bypass surgery patients taking Bextra, an anti-inflammatory in the same class as the recently withdrawn drug Vioxx, had a higher risk of stroke and heart attack...
USA Today story 11/10/2004 9:45 PM
->Read More...
A study suggesting arthritis drug Bextra doubles patients' heart attack and stroke risks ...
Pfizer reacts with a Press Release, rather than a warning about strokes and heart attacks.
->Read More...
Pfizer Inc said a New York Times article published today draws unsubstantiated conclusions about the cardiovascular safety of its COX-2 medicine Bextra and is based on information that has not been published in a medical journal or subject to independent scientific review...
|
